(Date:11/23/2009)... Hampshire microbiologist Louis Tisa has received ...ing of the actinorhizal plants, widespread woody p...ontaminated soils. , The United States Departme... of molecular, cellular and biomedical sciences, $...een the bacteria Frankia and Casuarina, an actinor...
(Date:11/23/2009)... , , , , , , , ... Dr Andrew Marshall, from the Environment Departme...ery of Kinyongia magomberae and his wider work i...re information. , , , , , ... , , , , , , A new species of chamel...
(Date:11/23/2009)...ector of the Interuniversity Professorship in Law ... University of the Basque Country. The Professorsh...r experts such as researchers in the fields of mol...thics. , The Interuniversity Professorship in La...sto and the Basque Country was created in 1993. Th...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research and legislation should go hand in hand, as much as possible 2Stryker Announces Agreements To Acquire Assets 6148 1Stryker Announces Agreements To Acquire Assets 6148 2Stryker Announces Agreements To Acquire Assets 6148 3Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17 6146 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 2Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 3Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 4Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 5Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 6(Date:11/20/2009)...v. 20 Veridiam (www.veridiam.com) ...company category at the 2009 Workplace Excellence ...Society for Human Resources Management and recogni...tices. ,, Veridiam was one of nine winners, sel...ies, honored at the recent awards ceremony. San Di...
(Date:11/20/2009)...Md., Nov. 20 Novavax, In...iced an underwritten public offering of 6,800,000 ...c of $3.30 per share. The approximately $21 milli...ng discounts and commissions, will be used for pre...sed vaccines, internal research and development pr...
(Date:11/20/2009)...Nov. 20 Cell Therapeutic...ay that the Ninth Circuit Court of Appeals reverse...hould be allowed to pursue all of its claims again...strict Court for trial. CTI filed a complaint aga...bursement consultant for CTI,s product TRISENOX, i...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domin...The Role of Process Analytical Technology (PAT) in...ecember 1, 2009. , (PRWEB...cess Analytical Technology (PAT) in Green Chemistr...ocess Analytical Technology (PAT) case studies wil...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2...e Board of,Directors of Shire plc (LSE: SHP) (NASD...al company, announces today that Michael Rosenblat...ctor with immediate effect., Dr Rosenblatt is the...n, Massachusetts. He was previously Professor of M...n senior research positions at the Beth,Israel Dea...
...,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announ...ical Officer of BioMarin, will present a,company u...ugged Conference,in Key Biscayne, Florida on Thurs...ties may access a live audio webcast of the presen...bsite, http://www.BMRN.com . A,replay of the pres...
...r,BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE...rey Jr. to form Cardio Derma Clinical Partners,(CD...general partner, will,fund a minimum of $1,000,000...of CVBT,s wound healing drug candidate., "R&D Par...by some of,today,s biggest names in biotechnology ...
Other Biology Technology:Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4BioMarin to Present at the Morgan Stanley Healthcare Conference 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 3Mouse Anti-p230 trans Golgi Monoclonal Antibody, Unconjugated, Clone 15 from BD Biosciences Pharmingen
...s intensely fluorescent and highly photostable Flu...use in a variety of applications requiring probes ...rotein- and other macromolecule-labeled microspher... bind to non-target surfaces in some applications....
DNA Polymerase I Large (Klenow) Fragment from Invitrogen
...chium album Description: Proteinase K is a high...range of applications purified from the fungus T. ...he carboxyl group of N-substituted hydrophobic ali...fied as a serine protease. Proteinase K is useful ...
Biology Products: